India - English - Central Drugs Standard Control Organization

ch.bhagat - daunorubicin hcl. - inj - 20mg - vial

India - English - Central Drugs Standard Control Organization

cipla - daunorubicin - inj - 20mg - 10ml

India - English - Central Drugs Standard Control Organization

cadila ph. - daunorubicin - vial - 20mg(+mannitol 200mg) - 1

Israel - English - Ministry of Health

novartis israel ltd - ondansetron as hydrochloride dihydrate - solution for injection - ondansetron as hydrochloride dihydrate 2 mg/ml - ondansetron - ondansetron - adults:zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. zofran is indicated for the prevention and treatment of post-operative nausea and vomiting (ponv). paediatric population:zofran is indicated for the management of chemotherapy-induced nausea and vomiting (cinv) in children aged ≥6 months, and for the prevention and treatment of ponv in children aged ≥ 1 month.

European Union - English - EMA (European Medicines Agency)

novartis europharm ltd - midostaurin - leukemia, myeloid, acute; mastocytosis - antineoplastic agents - rydapt is indicated:in combination with standard daunorubicin and cytarabine induction and high dose cytarabine consolidation chemotherapy, and for patients in complete response followed by rydapt single agent maintenance therapy, for adult patients with newly diagnosed acute myeloid leukaemia (aml) who are flt3 mutation positive (see section 4.2);as monotherapy for the treatment of adult patients with aggressive systemic mastocytosis (asm), systemic mastocytosis with associated haematological neoplasm (sm ahn), or mast cell leukaemia (mcl).

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmaco australia ltd - tretinoin, quantity: 10 mg - capsule, soft - excipient ingredients: purified water; glycerol; yellow beeswax; iron oxide yellow; gelatin; titanium dioxide; iron oxide red; soya oil; partially hydrogenated soya oil; hydrogenated soya oil; maize starch; sorbitol; mannitol - vesanoid should be used for induction of remission in acute promyelocytic leukemia (apl; fab classification aml-m3). previously untreated patients as well as patients who relapse after or are refractory to standard chemotherapy (daunorubicin and cytosine arabinoside (ara-c)or equivalent therapies) may be treated with vesanoid. following complete remission, consolidation full dose chemotherapy should be employed. a loss of responsiveness to vesanoid has been reported among patients maintained on vesanoid. the median time to relapse for patients maintained on vesanoid is 4 to 6 months.

Namibia - English - Namibia Medicines Regulatory Council

pfizer laboratories (pty) ltd - daunorubicin hydrochloride - injectable solution - 20mg

Malta - English - Medicines Authority

jv healthcare limited navi buidlings, pantar road, lija, lja 2021, malta - powder and solvent for solution for injection - daunorubicin 20 mg - antineoplastic agents

Israel - English - Ministry of Health

novartis israel ltd - ciclosporin - solution for infusion - ciclosporin 50 mg/ml - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation.

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - ciclosporin - capsule, liquid filled - 10.0mg - ciclosporin 10.0mg